Riskpilot← Back to searchSign inGet full accessTULLIN SPECSAVERS AS
ASActiveOrg 929059662Pilestredet 25, 0164 OsloRetail sale of medical and orthopaedic goods · NACE 4774Est. 20225 employees
Revenue 2025
NOK 6,8M
-1% vs 2024
EBITDA margin
-4.9%
+57% vs 2024
Equity ratio
-26.4%
Financial strength
Net profit 2025
NOK -959K
+37% vs 2024
| Revenue | NOK 6,8M | -1% |
| EBITDA | NOK -332K | +57% |
| Net profit | NOK -959K | +37% |
| Total assets | NOK 2,5M | -11% |
| Equity | NOK -671K | -333% |
| Employees | 5 | — |
Legal name
TULLIN SPECSAVERS AS
Org number
929059662
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
9. april 2022
Share capital
NOK 30 125
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-02-28
Financial year
January – December
Signatory rights
Pernille genckel
Company purpose
Handel med optiske varer samt det som naturlig står i forbindelse med dette.
Address
Pilestredet 25, 0164 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 1 026 | 6 875 | 6 836 |
| Staff expenses | −439 | −2 388 | −2 256 |
| EBITDA | −181 | −780 | −332 |
| Depreciation & amort. | −34 | −675 | −623 |
| EBIT | −215 | −1 455 | −955 |
| Net financials | −0 | −66 | −3 |
| Profit before tax | −215 | −1 521 | −959 |
| Tax | −0 | −0 | −0 |
| Net profit | −215 | −1 521 | −959 |
| Item | 2022 | 2024 | 2025 |
|---|---|---|---|
| Total assets | 2 292 | 2 845 | 2 536 |
| Equity | −191 | 288 | −671 |
| Long-term debt | 1 500 | 0 | 0 |
| Short-term debt | 983 | 2 557 | 3 207 |
| Total debt | 2 483 | 2 557 | 3 207 |
EBITDA margin
-4.9%
This company
15.8%
Market median
-131% vs market
20222025
Equity ratio
-26.4%
This company
38.2%
Market median
-169% vs market
20222025
Return on equity
-95868100.0%
This company
18.4%
Market median
-521022383% vs market
20222025
Net profit margin
-14.0%
This company
8.1%
Market median
-273% vs market
20222025
Asset turnover
2.70×
This company
1.12×
Market median
+141% vs market
20222025
Debt / equity
4.78×
This company
0.62×
Market median
-671% vs market
20222025
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
NH Chief Executive Officer | Chief Executive Officer | 2024 |
| Former (3) | ||
SK Chief Executive Officer | Chief Executive Officer | 2023 – 2024 |
JB Chief Executive Officer | Chief Executive Officer | 2024 – 2024 |
BS Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2024 | |
| Board of Directors | 2024 | |
| Former (2) | ||
| Chairman | 2022 – 2023 | |
| Chairman | 2022 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 75% | 75% | 2022 | |
Norway Specsavers Ltd | Company | 50.21% | 50.21% | 2024 |
| Company | 49.79% | 49.79% | 2024 | |
| Company | 25% | 25% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of TULLIN SPECSAVERS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Nina Helen Kleppe | Chief Executive Officer | 0 companies |
| Sindre Knight Stenhammer | Chief Executive Officer | 0 companies |
| Jan-Kristian Bjerke | Chief Executive Officer | 0 companies |
| Børre Sand | Chief Executive Officer | 0 companies |
| Richard Neil Owens | Chairman | 0 companies |
| Lars Grytli Seim | Chairman | 0 companies |
| Henning Jørgen Eriksen Færden | Board of Directors | 0 companies |
| Tore Olstad Syvertsen | Chairman | 0 companies |